These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25847395)

  • 21. T-lymphocyte calcium influx characteristics and their modulation by Kv1.3 and IKCa1 channel inhibitors in the neonate.
    Toldi G; Treszl A; Pongor V; Gyarmati B; Tulassay T; Vásárhelyi B
    Int Immunol; 2010 Sep; 22(9):769-74. PubMed ID: 20601376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the innate immune system in pediatric inflammatory bowel disease.
    Schirbel A; Fiocchi C
    Expert Rev Gastroenterol Hepatol; 2011 Feb; 5(1):33-41. PubMed ID: 21309670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting T-cell migration in inflammatory bowel disease.
    Marsal J; Agace WW
    J Intern Med; 2012 Nov; 272(5):411-29. PubMed ID: 22946654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A potential role for regulatory T-cells in the amelioration of DSS induced colitis by dietary non-digestible polysaccharides.
    Hartog A; Belle FN; Bastiaans J; de Graaff P; Garssen J; Harthoorn LF; Vos AP
    J Nutr Biochem; 2015 Mar; 26(3):227-33. PubMed ID: 25498760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nitric oxide and inflammatory bowel disease].
    García-González MA; Peña AS
    Rev Esp Enferm Dig; 1998 Dec; 90(12):870-6. PubMed ID: 9973849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation antigens on colonic T cells in inflammatory bowel disease: effects of IL-10.
    Ebert EC; Mehta V; Das KM
    Clin Exp Immunol; 2005 Apr; 140(1):157-65. PubMed ID: 15762887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis of inflammatory bowel disease: evolving concepts.
    Mayer L; Yio XY; Lin A; Panja A
    Mt Sinai J Med; 1996; 63(3-4):202-9. PubMed ID: 8692166
    [No Abstract]   [Full Text] [Related]  

  • 28. Inner mitochondrial maxi-K⁺ channels in neonatal renal tubular cells: novel therapeutic targets to control apoptosis.
    Kazama I; Maruyama Y
    Med Hypotheses; 2012 Jun; 78(6):800-1. PubMed ID: 22498048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular pathogenesis of inflammatory bowel disease: genotypes, phenotypes and personalized medicine.
    Goyette P; Labbé C; Trinh TT; Xavier RJ; Rioux JD
    Ann Med; 2007; 39(3):177-99. PubMed ID: 17457716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting gut T cell Ca2+ release-activated Ca2+ channels inhibits T cell cytokine production and T-box transcription factor T-bet in inflammatory bowel disease.
    Di Sabatino A; Rovedatti L; Kaur R; Spencer JP; Brown JT; Morisset VD; Biancheri P; Leakey NA; Wilde JI; Scott L; Corazza GR; Lee K; Sengupta N; Knowles CH; Gunthorpe MJ; McLean PG; MacDonald TT; Kruidenier L
    J Immunol; 2009 Sep; 183(5):3454-62. PubMed ID: 19648266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-cell-directed therapies in inflammatory bowel diseases.
    Monteleone G; Caprioli F
    Clin Sci (Lond); 2010 Mar; 118(12):707-15. PubMed ID: 20350293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different calcium influx characteristics upon Kv1.3 and IKCa1 potassium channel inhibition in T helper subsets.
    Orbán C; Bajnok A; Vásárhelyi B; Tulassay T; Toldi G
    Cytometry A; 2014 Jul; 85(7):636-41. PubMed ID: 24827427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unravelling the pathogenesis of inflammatory bowel disease.
    Xavier RJ; Podolsky DK
    Nature; 2007 Jul; 448(7152):427-34. PubMed ID: 17653185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Voltage-dependent potassium channel and calcium-activated potassium channel current changes of peripheral blood T-lymphocytes from hypertensive patients in Xinjiang Kazakh].
    Zhang QB; Zhang YM; Cheng LF; Yuan QY; Zhang GM; Liang P; Gou F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Dec; 41(12):1020-4. PubMed ID: 24524604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocyte homing in the pathogenesis of extra-intestinal manifestations of inflammatory bowel disease.
    Eksteen B; Miles AE; Grant AJ; Adams DH
    Clin Med (Lond); 2004; 4(2):173-80. PubMed ID: 15139741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial ligands and homing of mucosal leukocytes in extraintestinal manifestations of IBD.
    Salmi M; Jalkanen S
    Inflamm Bowel Dis; 1998 May; 4(2):149-56. PubMed ID: 9589300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological therapies of inflammatory bowel disease.
    van Deventer SJ
    Acta Gastroenterol Belg; 2001; 64(2):177-81. PubMed ID: 11475130
    [No Abstract]   [Full Text] [Related]  

  • 38. Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease.
    Henderson P; van Limbergen JE; Schwarze J; Wilson DC
    Inflamm Bowel Dis; 2011 Jan; 17(1):382-95. PubMed ID: 20645321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular fingerprints of neutrophil-dependent oxidative stress in inflammatory bowel disease.
    Naito Y; Takagi T; Yoshikawa T
    J Gastroenterol; 2007 Oct; 42(10):787-98. PubMed ID: 17940831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of disease: protease functions in intestinal mucosal pathobiology.
    Antalis TM; Shea-Donohue T; Vogel SN; Sears C; Fasano A
    Nat Clin Pract Gastroenterol Hepatol; 2007 Jul; 4(7):393-402. PubMed ID: 17607295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.